Fate Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $-13.3M | $-14.0M | $709.0K | $155.0K |
| FY2013 | $-15.4M | $-15.6M | $244.0K | $1.6M |
| FY2014 | $-22.4M | $-23.3M | $882.0K | $2.4M |
| FY2015 | $-18.4M | $-19.9M | $1.5M | $2.4M |
| FY2016 | $-29.8M | $-30.3M | $457.0K | — |
| FY2017 | $-36.8M | $-38.5M | $1.7M | — |
| FY2018 | $-38.7M | $-41.0M | $2.3M | — |
| FY2019 | $-83.2M | $-90.6M | $7.4M | — |
| FY2020 | $-39.2M | $-44.2M | $4.9M | — |
| FY2021 | $-162.9M | $-213.6M | $50.7M | — |
| FY2022 | $-248.2M | $-283.8M | $35.6M | — |
| FY2023 | $-132.3M | $-138.4M | $6.2M | — |
| FY2024 | $-122.9M | $-123.6M | $730.0K | — |
| FY2025 | $-106.1M | $-112.0M | $6.0M | — |